References
- 1. Sugiura T, Yamamoto K, Murakami K. Immune Thrombocytopenic Purpura Detected with Oral Hemorrhage: a Case Report. J Dent Shiraz Univ Med Sci. 2018;19:159-163.
- 2. Hazzan R, Mukamel M, Yacobovich J. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer. 2006;47:657-659.
- 3. Kuhne T. Diagnosis and management of immune thrombocytopenia in childhood. Hamostaseologie. 2017;37:36-44.
- 4. Seidel MG. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood. 2014;124:2337-2344.
- 5. Demir C, Esen R, Atmaca M, Efe S. Prevalence of Autoantibodies Related To Some Autoimmune Disorders in Patients With Chronic Idiopathic Thrombocytopenic Purpura. Clin Appl Thromb Hemost. 2011;17:E114-118.
- 6. Sangwan A, Tewari S, Narula SC. Significance of periodontal health in primary immune thrombocytopenia – a case report and review of literature. J Dent (Tehran). 2013;10:197-202.
- 7. Anaya J-MM. The diagnosis and clinical significance of polyautoimmunity. Autoimmun Rev. 2014;13:423-426.
- 8. Anaya J-M, Restrepo-Jimenez P, Rodriguez Y, et al. Sjogren’s Syndrome and Autoimmune Thyroid Disease: Two Sides of the Same Coin. Clin Rev Allergy Immunol. 2019;56:362-374.
- 9. Molano-González N, Rojas M, Monsalve DM, et al. Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity. J Autoimmun. 2019;98:24-32.
- 10. Mokhtar GM, Tantawy AA, El Sherif NH. Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia. Platelets. 2012;23:264-273.
- 11. D’Orazio JA, Neely J, Farhoudi N. ITP in children: pathophysiology and current treatment approaches. J Pediatr Hematol Oncol. 2013;35:1-13.
- 12. Neunert C, Despotovic J, Haley K, et al. Thrombopoietin receptor agonist use in children: data from the pediatric ITP consortium of North America ICON2 Study. Pediatr Blood Cancer. 2016;63:1407-1413.
- 13. Kim TO, Despotovic J, Lambert MP. Eltrombopag for use in children with immune thrombocytopenia. Blood Adv. 2018;2:454-461.
- 14. Giordano P, Urbano F, Lassandro G, et al. Role of antithyroid autoimmunity as a predictive biomarker of chronic immune thrombocytopenia. Pediatr Blood Cancer. 2018;e27452.
- 15. Hughes JW, Riddlesworth TD, DiMeglio LA. Autoimmune Diseases in Children and Adults with Type 1 Diabetes From the T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2016;101:4931-4937.
- 16. Bay A, Coskun E, Leblebisatan G, et al. Prevalence and clinical significance of antithyroid antibodies in children with immune thrombocytopenic purpura. Pediatric Hematol Oncol. 2013;30:698-704.
- 17. Liu Y, Chen S, Sun Y, et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study. Medicine (Baltimore). 2016;95:e5565.
- 18. Bride K, Teachey D. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. F1000Res. 2017;6:1928.
- 19. Karastaneva A, Klobassa DS, Minkov M, Benesch M, Seidel MG. Successful Treatment with SCIG of a Child with Refractory Chronic ITP. Journal of Clinical Immunology. 2019;39:19-22.
- 20. Setoue DN, Pitta AC, Fiorot FJ, et al. Symptomatic polyautoimmunity at diagnosis of 1463 childhood-onset lupus: A Brazilian multicenter study. Autoimmun Rev. 2018;17:836-839.